跳到主要內容

Atlas Venture Associates X, LLC 的 Form 4 申報

Generation Bio Co.(GBIO),2021/9/24 申報

申報編號
0001209191-21-057719
申報時間
2021/9/24 20:59 ET
交易日
2021/9/22-9/24
申報延遲
2 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 7 筆非衍生性交易。公開市場賣出合計 $351.2 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Atlas Venture Associates X, LLCCIK 0001742765持股 10% 以上大股東
Atlas Venture Associates X, L.P.CIK 0001742766持股 10% 以上大股東
Atlas Venture Opportunity Fund I, L.P.CIK 0001759241持股 10% 以上大股東
Atlas Venture Associates Opportunity I, LLCCIK 0001780066持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2021/9/22Common StockS賣出處分−30,560$25.89F2−$791,228.96185,126直接
2021/9/23Common StockS賣出處分−75,324$26.13F4−$1,968,442.09109,802直接
2021/9/23Common StockS賣出處分−1$26.55−$26.55109,801直接
2021/9/24Common StockS賣出處分−28,862$25.84F5−$745,765.2280,939直接
2021/9/22Common StockS賣出處分−57$25.89F2−$1,475.79951間接
2021/9/23Common StockS賣出處分−140$26.13F4−$3,658.62811間接
2021/9/24Common StockS賣出處分−54$25.84F4−$1,395.31757間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.54 to $26.21 inclusive. The Reporting Persons undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2),(4) and (5).

表 I 有 2 筆交易的價格引用這則附註。

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.53 to $26.518 inclusive.

表 I 有 3 筆交易的價格引用這則附註。

F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.40 to $26.21 inclusive.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)